SPIKE Act

Summary

Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 April 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

2. 3 April 2019

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 3 April 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 3 April 2019

   Introduced

   Introduced in House

   Source: IntroReferral

5. 4 April 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

6. 21 May 2019

   Committee

   Subcommittee Hearings Held.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 April 2019 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 April 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 April 2019

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 3 April 2019

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Horsford, Steven [D-NV-4] · D · Sponsor
• Rep. Reed, Tom [R-NY-23] · R · Sponsor
• Rep. Cox, TJ [D-CA-21] · D · Cosponsor
• Rep. Wild, Susan [D-PA-7] · D · Cosponsor
• Rep. Case, Ed [D-HI-1] · D · Cosponsor
• Rep. Houlahan, Chrissy [D-PA-6] · D · Cosponsor
• Rep. Raskin, Jamie [D-MD-8] · D · Cosponsor
• Rep. Spanberger, Abigail Davis [D-VA-7] · D · Cosponsor
• Sen. Slotkin, Elissa [D-MI] · D · Cosponsor
• Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
• Rep. Steil, Bryan [R-WI-1] · R · Cosponsor
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to → SPIKE Act
• related to ← Prescription Drug STAR Act